Anti-Mouse RANKL In Vivo Antibody – Low Endotoxin (IK22/5) [ICH1114]
$320.00 – $2,378.00
Bulk anti-RANKL In Vivo Antibody – Low Endotoxin (IK22/5)
Product Benefits:
ichorbio’s anti-RANKL In Vivo Antibody – Low Endotoxin (IK22/5) is manufactured in a cGMP compliant, ISO Quality Standard 9001:2015 facility. ichorbio’s low endotoxin antibodies have half the endotoxin of comparable antibodies from our competitors at less than 1.0 EU/mg. If ichorbio’s low endotoxin antibodies are not low enough we also offer ultra low endotoxin antibodies which have even less endotoxin (<0.75EU/mg) at an even higher purity (98% versus 95%). ichorbio offers Amazon vouchers or donations to the NC3Rs for reviews of this product: click here for more information. ichorbio: the best antibodies for in vivo research.
Target:
RANKL
Clone:
IK22/5
Isotype:
Rat IgG2a
Other Names:
Tumor necrosis factor ligand superfamily member 11, Tnfsf11, Osteoclast differentiation factor, ODF, Osteoprotegerin ligand, OPGL, Receptor activator of nuclear factor kappa-B ligand, TNF-related activation-induced cytokine, TRANCE, CD254
Uniprot:
Host:
Rat
Species Reactivity:
Mouse
Specificity:
Anti-RANKL In Vivo Antibody – Low Endotoxin (IK22/5) recognizes an epitope on Mouse RANKL
Purification Method:
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background:
RANKL (Receptor Activator for Nuclear Factor κ B Ligand), also known as TNF-related activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and ODF (osteoclast differentiation factor), is a member of the tumor necrosis factor family cytokine. RANKL is essential for osteoclast formation, activation, and survival. RANKL through interaction with its receptor RANK can modulate matrix degradation and inflammation. RANKL and RANK have essential roles in lymph node formation, establishment of the thymic microenvironment, and development of a lactating mammary gland during pregnancy. Consequently, novel drugs specifically targeting RANK, RANKL, and their signaling pathways in osteoclasts are expected to revolutionize the treatment of various ailments associated with bone loss, such as arthritis, periodontal disease, cancer metastases, and osteoporosis.
Immunogen:
Purified Recombinant Mouse RANKL (NSO-derived)
Concentration:
1.0 mg/ml
Formulation:
0.01 M phosphate buffered saline (PBS) pH 7.2, 150 mM NaCl with no carrier protein, potassium or preservatives added. BSA and Azide free.
Purity:
>95% by SDS-PAGE and HPLC
>98% by SDS-PAGE and HPLC
Endotoxin:
<0.5 EU/mg as determined by the LAL method
≤ 0.75 EU/mg as determined by the LAL method
Aggregation:
Aggregation level ≤ 5%
Aggregation level ≤ 1%
Storage:
anti-RANKL In Vivo Antibody – Low Endotoxin (IK22/5) is stable when stored at 2-8°C. Do not freeze.This antibody is
Applications:
Flow Cytometry, Immunoprecipitation, Western Blot, Blocking, Immunofluorescence, IHC (Frozen)
Application Notes:
Each investigator should determine their own optimal working dilution for specific applications.
Use:
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Isotype Control:
Be the first to review “Anti-Mouse RANKL In Vivo Antibody – Low Endotoxin (IK22/5) [ICH1114]”
Related products
$320.00 – $2,378.00
Isotype Controls
Rat IgG2b In Vivo Isotype Control – Low Endotoxin (1-2) [ICH2243]
$320.00 – $2,378.00
$320.00 – $2,378.00
$320.00 – $2,378.00
Reviews
There are no reviews yet.